Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H.A. Azim
Tellomak: T-Cell Lymphoma Anti-Kir3dl2 Therapy: An Open Label, Multi-Cohort, Multi-Center, International Phase Ii Study Evaluating the Efficacy and Safety of Iph4102 Alone or in Combination With Chemotherapy in Patients With Advanced T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Multi-Center Phase Ii Study of Oral Azacitidine (Cc-486) Plus Chop as Initial Treatment for Peripheral T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Preclinical Efficacy of Belinostat in Combination With Zidovudine in Adult T-Cell Leukemia-Lymphoma
Retrovirology
Virology
Infectious Diseases
Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study
Clinical Therapeutics
Pharmacology
A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Safety and Activity of Ibrutinib in Combination With Durvalumab in Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B‐cell Lymphoma
American Journal of Hematology
Hematology
Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (Aitl) and Cxcl12+ Peripheral T-Cell Lymphoma (Ptcl): Preliminary Results From a Phase 2 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Long‐term Efficacy and Safety of Bexarotene for Japanese Patients With Cutaneous T‐cell Lymphoma: The Results of a Phase 2 Study (B‐1201)
Journal of Dermatology
Dermatology
Medicine
Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Older, Vulnerable Patients With Relapsed/Refractory Large B-Cell Lymphoma
Haematologica
Hematology
